查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1605708

核糖核酸市场，按类型、技术、交付方式、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Ribonucleic Acid Market, By Type, By Technology, By Delivery Method, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 345 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023 年核糖核酸市场规模为 3.45 亿美元，2024 年至 2032 年复合年增长率为 8.5%。

核糖核酸市场-市场动态

对基因疗法日益浓厚的兴趣推动核糖核酸市场的扩张

人们对基因疗法日益增长的兴趣极大地促进了核糖核酸 (RNA) 市场的扩张，特别是随着 mRNA 疗法的进步。例如，2023 年，美国食品药物管理局 (FDA) 批准了几种新的基于 RNA 的治疗方法，增强了遗传性疾病和癌症的治疗选择。对基于 RNA 的研究投资的增加进一步促进了市场的成长，Moderna 和默克之间的合作等着名合作旨在利用 RNA 进行癌症治疗。 mRNA 疫苗的成功，特别是在 COVID-19 大流行期间，进一步提高了人们的认识并加速了 RNA 技术在更广泛的医疗应用中的探索。由于 RNA 有潜力透过针对遗传疾病来彻底改变医疗保健，因此专注于 RNA 疗法的研究经费和临床试验数量都出现了大幅增长。这一转变与全球对个人化医疗和精准治疗日益增长的兴趣相一致，将 RNA 确立为现代生物技术的核心焦点。

核糖核酸市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 8.5% 左右的复合年增长率成长

根据类型细分，mRNA（信使 RNA）预计将在 2023 年显示最大的市场份额

从技术细分来看，RNA定序是2023年的主导类型

根据递送方式细分，脂质奈米颗粒是 2023 年的主导类型

按地区划分，北美是 2023 年的主要收入来源

核糖核酸市场-細項分析：

全球核糖核酸市场根据类型、技术、交付方法、最终用户和地区进行细分。

市场依类型分为三类：mRNA（信使RNA）、rRNA（核醣体RNA）和tRNA（转移RNA）。 mRNA（信使RNA）因其在疫苗开发和基因治疗中的突出作用而具有最高优先级。 rRNA（核醣体 RNA）对蛋白质合成至关重要，而 tRNA（转移 RNA）则支持细胞过程中的翻译。

根据技术，市场分为三类：RNA定序、基于PCR的RNA分析、微阵列分析。 RNA 定序因其分析转录组和基因表现的能力而成为领先技术。基于 PCR 的 RNA 分析是基因扩增的可靠方法，而微阵列分析则用于基因表现谱分析。

核糖核酸市场-地理洞察

在生物技术公司高度集中和对 RNA 研究的大量投资的推动下，北美目前在核糖核酸 (RNA) 市场中处于领先地位。 2023 年，mRNA 领域的主要参与者 Moderna 扩大了其在美国基于 mRNA 的疫苗生产设施，凸显了该地区在 RNA 治疗领域的主导地位。美国政府也增加了对 RNA 研究的资助，例如美国国立卫生研究院 (NIH) 对基因疗法的投资等措施。欧洲紧随其后，英国和德国等国家在基于 RNA 的药物的临床试验和监管审批方面取得了重大进展。在亚太地区，中国和日本由于生物技术领域的不断扩大，正在成为重要的参与者，日本将于2024 年批准第一个基于mRNA 的癌症疫苗。了诊断工具和基于 RNA 的药物生产，促进了全球市场活动的增加。

核糖核酸市场-竞争格局：

北美继续引领核糖核酸 (RNA) 市场的竞争格局，这主要是由 Moderna、辉瑞和 CureVac 等行业巨头推动的。 2023 年，Moderna 将研究范围扩大到基于 mRNA 的癌症疫苗，这是肿瘤学领域的重大倡议。辉瑞与 BioNTech 一起致力于推进其 RNA 疫苗产品组合，包括罕见遗传性疾病的治疗。在欧洲，BioNTech和阿斯特捷利康等公司正在积极开发RNA疗法并在RNA疫苗研究方面进行合作。一项值得注意的合作关係是 BioNTech 与罗氏在 2024 年结盟，共同开发针对传染病的 mRNA 疫苗。同时，在亚太地区，中国的科兴生物正进入RNA治疗领域，反映出该地区对生物技术的日益关注。该地区还受益于 RNA 研究的策略性投资以及大学和生物技术公司之间的合作。併购继续影响市场，一些专注于 RNA 的小型新创公司被大型製药公司收购，以增强其基于 RNA 的产品。

最新进展：

2024 年 9 月，Cytiva 为其 NanoAssemblr Ignite 平台推出了先进的 RNA 递送 LNP 试剂盒。此创新试剂盒旨在增强 RNA 疗法的配方和交付，简化基于 mRNA 的疗法的开发流程并改善患者的治疗效果。

2024 年 10 月，Judo Bio 启动了 A 系列融资，以推进其肾臟标靶 siRNA 疗法。该计划旨在开发肾臟疾病的创新疗法，利用 RNA 技术改善患者的治疗效果并解决肾臟健康方面未满足的医疗需求。

目录

第一章：核糖核酸市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按类型分類的核糖核酸市场片段
    • 依技术分類的核糖核酸市场片段
    • 以交付方式分類的核糖核酸市场片段
    • 最终用户的核糖核酸市场片段
    • 按国家分類的核糖核酸市场片段
    • 按地区分類的核糖核酸市场片段
  • 竞争洞察

第 3 章：核糖核酸主要市场趋势

  • 核糖核酸市场驱动因素
    • 市场驱动因素的影响分析
  • 核糖核酸市场限制
    • 市场限制影响分析
  • 核糖核酸市场机会
  • 核糖核酸市场未来趋势

第 4 章：核糖核酸产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：核糖核酸市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：核糖核酸市场格局

  • 2023 年核糖核酸市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：核糖核酸市场 - 按类型

  • 概述
    • 按类型分類的细分市场占有率分析
    • mRNA（信使RNA）
    • rRNA（核醣体RNA）
    • tRNA（转移RNA）
    • 其他的

第 8 章：核糖核酸市场 - 依技术分类

  • 概述
    • 按技术分類的细分市场份额分析
    • RNA定序
    • 基于 PCR 的 RNA 分析
    • 微阵列分析

第 9 章：核糖核酸市场 - 依交付方式

  • 概述
    • 按交付方式分類的细分市场份额分析
    • 脂质奈米颗粒
    • 电穿孔
    • 病毒载体

第 10 章：核糖核酸市场 - 依最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 製药公司
    • 生技公司
    • 学术研究机构
    • 医院和诊断实验室

第 11 章：核糖核酸市场 - 依地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美核糖核酸主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按类型）
    • 北美市场规模和预测（按技术）
    • 北美市场规模和预测（按交付方式）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲核糖核酸主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按类型）
    • 欧洲市场规模与预测（按技术）
    • 欧洲市场规模和预测（按交付方式）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区核糖核酸主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按类型）
    • 亚太地区市场规模与预测（按技术）
    • 亚太地区市场规模与预测（以交付方式）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲核糖核酸主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按类型）
    • 拉丁美洲市场规模与预测（按技术）
    • 拉丁美洲市场规模和预测（以交付方式）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲核糖核酸主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按类型）
    • 中东和非洲市场规模及预测（按技术）
    • 中东和非洲市场规模及预测（以交付方式）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 12 章：主要供应商分析 - 核糖核酸产业

  • 竞争仪表板
  • 公司简介
    • Abcam Plc
    • Agilent Technologies, Inc.
    • Alnylam Pharmaceuticals, Inc.
    • BioNTech SE
    • Bio-Rad Laboratories Inc.
    • GSK plc
    • Illumina, Inc.
    • Ionis Pharmaceuticals, Inc.
    • Lonza Group Ltd.
    • Moderna, Inc.
    • Oxford Nanopore Technologies
    • Qiagen NV
    • Regeneron Pharmaceuticals, Inc.
    • Roche Diagnostics
    • Sarepta Therapeutics, Inc.
    • Thermo Fisher Scientific Inc.
    • Others

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4353

REPORT HIGHLIGHT

Ribonucleic Acid Market size was valued at USD 345 Million in 2023, expanding at a CAGR of 8.5% from 2024 to 2032.

The ribonucleic acid (RNA) market is primarily focused on the study and use of RNA molecules for various research, diagnostic, and therapeutic applications. RNA plays a critical role in cellular processes, and its potential in gene expression regulation and therapeutic delivery is expanding. Increased demand for RNA-based therapies, such as RNA vaccines, is a key factor behind the market's growth, as seen with the success of COVID-19 mRNA vaccines developed by companies like Moderna and Pfizer. Additionally, the growing interest in gene therapies, RNA interference (RNAi) treatments, and advancements in genomic research provide further momentum. However, challenges such as the high cost of RNA-based therapies and concerns about RNA stability and delivery methods hinder widespread adoption. Opportunities for growth exist in emerging markets, especially with increasing investments in biotech startups and expanding research in oncology, rare genetic disorders, and autoimmune diseases, where RNA-based treatments show significant promise. In 2023, investments in RNA technology increased by over 15%, reflecting a strong commitment to innovation.

Ribonucleic Acid Market- Market Dynamics

Growing Interest in Gene Therapies Drives Expansion in the Ribonucleic Acid Market

The growing interest in gene therapies is significantly contributing to the expansion of the ribonucleic acid (RNA) market, particularly with advancements in mRNA therapeutics. In 2023, for example, the U.S. Food and Drug Administration (FDA) approved several new RNA-based treatments, enhancing treatment options for genetic disorders and cancers. A rise in investments in RNA-based research is further bolstering the market's growth, with notable collaborations such as the partnership between Moderna and Merck, which aims to leverage RNA for cancer treatment. The success of mRNA vaccines, especially during the COVID-19 pandemic, has further raised awareness and accelerated the exploration of RNA technologies for broader medical applications. With the potential for RNA to revolutionize healthcare by targeting genetic diseases, there is substantial growth in both research funding and the number of clinical trials focused on RNA therapies. This shift aligns with a growing global interest in personalized medicine and precision treatments, establishing RNA as a core focus in modern biotechnology.

Ribonucleic Acid Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.5% over the forecast period (2024-2032)

Based on Type segmentation, mRNA (messenger RNA) was predicted to show maximum market share in the year 2023

Based on Technology segmentation, RNA Sequencing was the leading type in 2023

Based on Delivery Method segmentation, Lipid nanoparticles were the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Ribonucleic Acid Market- Segmentation Analysis:

The Global Ribonucleic Acid Market is segmented on the basis of Type, Technology, Delivery Method, End-User, and Region.

The market is divided into three categories based on Type: mRNA (messenger RNA), rRNA (ribosomal RNA), and tRNA (transfer RNA). mRNA (messenger RNA) holds the highest priority due to its prominent role in vaccine development and gene therapies. rRNA (ribosomal RNA) follows as it is crucial for protein synthesis, while tRNA (transfer RNA) supports translation in cellular processes.

The market is divided into three categories based on Technology: RNA Sequencing, PCR-based RNA Analysis, and Microarray Analysis. RNA sequencing is the leading technology due to its ability to analyze transcriptomes and gene expression. PCR-based RNA analysis follows as a reliable method for gene amplification, while microarray analysis is used for gene expression profiling.

Ribonucleic Acid Market- Geographical Insights

North America is currently leading the ribonucleic acid (RNA) market, driven by the high concentration of biotech firms and substantial investments in RNA research. In 2023, Moderna, a key player in the mRNA space, expanded its mRNA-based vaccine production facilities in the U.S., underscoring the region's dominance in RNA therapeutics. The U.S. government has also increased funding for RNA research, with initiatives like the National Institutes of Health's (NIH) investment in gene-based therapies. Europe follows closely, with countries like the UK and Germany making significant strides in clinical trials and regulatory approvals for RNA-based drugs. In Asia-Pacific, China and Japan are emerging as important players due to their expanding biotech sectors, with Japan's approval of the first mRNA-based cancer vaccine in 2024. These regions are not only accelerating RNA-based therapies but also increasing the availability of diagnostic tools and RNA-based drug production, contributing to a global increase in market activity.

Ribonucleic Acid Market- Competitive Landscape:

North America continues to lead the competitive landscape of the ribonucleic acid (RNA) market, largely driven by industry giants like Moderna, Pfizer, and CureVac. In 2023, Moderna expanded its research into mRNA-based vaccines for cancer, a significant move in the oncology sector. Pfizer, alongside BioNTech, has focused on advancing its RNA vaccine portfolio, including treatments for rare genetic disorders. In Europe, companies such as BioNTech and AstraZeneca are actively developing RNA therapies and collaborating on RNA vaccine research. A notable partnership was the 2024 alliance between BioNTech and Roche to co-develop mRNA vaccines for infectious diseases. Meanwhile, in Asia-Pacific, China's Sinovac is entering the RNA therapeutics space, reflecting the region's growing focus on biotechnology. The region is also benefiting from strategic investments in RNA research and collaborations between universities and biotech firms. Mergers and acquisitions continue to shape the market, with several smaller RNA-focused startups being acquired by larger pharmaceutical companies to enhance their RNA-based offerings.

Recent Developments:

In September 2024, Cytiva launched an advanced RNA delivery LNP kit for its NanoAssemblr Ignite platform. This innovative kit is designed to enhance the formulation and delivery of RNA therapeutics, streamlining the development process for mRNA-based therapies and improving patient outcomes.

In October 2024, Judo Bio launched a Series A funding round to advance its kidney-targeted siRNA therapies. This initiative aims to develop innovative treatments for kidney diseases, leveraging RNA technology to improve patient outcomes and address unmet medical needs in renal health.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RIBONUCLEIC ACID MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abcam Plc
  • Agilent Technologies, Inc.
  • Alnylam Pharmaceuticals, Inc.
  • BioNTech SE
  • Bio-Rad Laboratories Inc.
  • GSK plc
  • Illumina, Inc.
  • Ionis Pharmaceuticals, Inc.
  • Lonza Group Ltd.
  • Moderna, Inc.
  • Oxford Nanopore Technologies
  • Qiagen N.V.
  • Regeneron Pharmaceuticals, Inc.
  • Roche Diagnostics
  • Sarepta Therapeutics, Inc.
  • Thermo Fisher Scientific Inc.
  • Others

GLOBAL RIBONUCLEIC ACID MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • mRNA (messenger RNA)
  • rRNA (ribosomal RNA)
  • tRNA (transfer RNA)
  • Others

GLOBAL RIBONUCLEIC ACID MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • RNA Sequencing
  • PCR-based RNA Analysis
  • Microarray Analysis

GLOBAL RIBONUCLEIC ACID MARKET, BY DELIVERY METHOD- MARKET ANALYSIS, 2019 - 2032

  • Lipid Nanoparticles
  • Electroporation
  • Viral Vectors

GLOBAL RIBONUCLEIC ACID MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Academic Research Institutes
  • Hospitals & Diagnostic Laboratories

GLOBAL RIBONUCLEIC ACID MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Ribonucleic Acid Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Ribonucleic Acid Market Snippet by Type
    • 2.1.2. Ribonucleic Acid Market Snippet by Technology
    • 2.1.3. Ribonucleic Acid Market Snippet by Delivery Method
    • 2.1.4. Ribonucleic Acid Market Snippet by End-User
    • 2.1.5. Ribonucleic Acid Market Snippet by Country
    • 2.1.6. Ribonucleic Acid Market Snippet by Region
  • 2.2. Competitive Insights

3. Ribonucleic Acid Key Market Trends

  • 3.1. Ribonucleic Acid Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Ribonucleic Acid Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Ribonucleic Acid Market Opportunities
  • 3.4. Ribonucleic Acid Market Future Trends

4. Ribonucleic Acid Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Ribonucleic Acid Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Ribonucleic Acid Market Landscape

  • 6.1. Ribonucleic Acid Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Ribonucleic Acid Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. mRNA (messenger RNA)
    • 7.1.3. rRNA (ribosomal RNA)
    • 7.1.4. tRNA (transfer RNA)
    • 7.1.5. Others

8. Ribonucleic Acid Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2023 & 2032 (%)
    • 8.1.2. RNA Sequencing
    • 8.1.3. PCR-based RNA Analysis
    • 8.1.4. Microarray Analysis

9. Ribonucleic Acid Market - By Delivery Method

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Delivery Method, 2023 & 2032 (%)
    • 9.1.2. Lipid Nanoparticles
    • 9.1.3. Electroporation
    • 9.1.4. Viral Vectors

10. Ribonucleic Acid Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Pharmaceutical Companies
    • 10.1.3. Biotechnology Companies
    • 10.1.4. Academic Research Institutes
    • 10.1.5. Hospitals & Diagnostic Laboratories

11. Ribonucleic Acid Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Ribonucleic Acid Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Ribonucleic Acid Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Ribonucleic Acid Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Ribonucleic Acid Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Ribonucleic Acid Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Ribonucleic Acid Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Abcam Plc
    • 12.2.2. Agilent Technologies, Inc.
    • 12.2.3. Alnylam Pharmaceuticals, Inc.
    • 12.2.4. BioNTech SE
    • 12.2.5. Bio-Rad Laboratories Inc.
    • 12.2.6. GSK plc
    • 12.2.7. Illumina, Inc.
    • 12.2.8. Ionis Pharmaceuticals, Inc.
    • 12.2.9. Lonza Group Ltd.
    • 12.2.10. Moderna, Inc.
    • 12.2.11. Oxford Nanopore Technologies
    • 12.2.12. Qiagen N.V.
    • 12.2.13. Regeneron Pharmaceuticals, Inc.
    • 12.2.14. Roche Diagnostics
    • 12.2.15. Sarepta Therapeutics, Inc.
    • 12.2.16. Thermo Fisher Scientific Inc.
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us